SCHEMBL26088366

SCHEMBL26088366

CC(C)(C)c1ccc2[nH]c3ccc(C(C)(C)C)c(C(N)=O)c3c2c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 8/20 0.47
GABRA1 P14867 1/20 0.43
GABRG2 P18507 1/20 0.43
GABRB3 P28472 1/20 0.43
GABRA5 P31644 1/20 0.43
GABRA3 P34903 1/20 0.43
GABRA2 P47869 1/20 0.43
GABRA4 P48169 1/20 0.43
GABRA6 Q16445 1/20 0.43
LRRK2 Q5S007 1/20 0.39
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37
GHSR Q92847 1/20 0.36
SCN10A Q9Y5Y9 4/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
HTR1D P28221 1/20 0.35
SIRT1 Q96EB6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22044196 0.77 KIF11 (0.54) KIF11GABRA1GABRG2GABRB3GABRA5
SCHEMBL725164 0.74 KIF11 (0.63) KIF11GABRA1GABRG2GABRB3GABRA5
SCHEMBL32668555 0.74 KIF11 (0.63) KIF11GABRA1GABRG2GABRB3GABRA5
SCHEMBL2054578 0.73 KIF11 (0.46) KIF11GABRA1GABRG2GABRB3GABRA5
SCHEMBL25243502 0.72 KIF11 (0.65) KIF11GABRA1GABRG2GABRB3GABRA5
SCHEMBL30577796 0.72 KIF11 (0.65) KIF11GABRA1GABRG2GABRB3GABRA5
SCHEMBL30577798 0.72 KIF11 (0.65) KIF11GABRA1GABRG2GABRB3GABRA5
Methyl Alcohol SCHEMBL4018989 0.72 KIF11 (0.75) KIF11GABRA1GABRG2GABRB3GABRA5
SCHEMBL29535 0.72 KIF11 (0.81) KIF11GABRA1GABRG2GABRB3GABRA5
SCHEMBL29361452 0.72 KIF11 (0.81) KIF11GABRA1GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230129371-A1 STERICALLY HINDERED PHOSPHINO-UREA SUPPORTED NICKEL (II) OR PALLADIUM (II) CATALYSTS FOR THE COPOLYMERIZATION OF ETHYLENE AND POLAR COMONOMERS DOW GLOBAL TECHNOLOGIES LLC (US) 2023-04-27 US disclosed
CN-115485312-A Sterically hindered phosphino-urea supported nickel (II) or palladium (II) catalysts for copolymerization of ethylene and polar comonomers 陶氏环球技术有限责任公司 2022-12-16 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230129371-A1 STERICALLY HINDERED PHOSPHINO-UREA SUPPORTED NICKEL (II) OR PALLADIUM (II) CATALYSTS FOR THE COPOLYMERIZATION OF ETHYLENE AND POLAR COMONOMERS PCNA, NIT2, MCM7 KIF11 3734/4885GABRA1 4470/4885GABRG2 4337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.